Renaissance Technologies, led by Jim Simons (Trades, Portfolio), has recently bolstered its investment in Exelixis Inc (NASDAQ:EXEL), a notable player in the biopharmaceutical industry. The transaction, which took place on December 19, 2023, saw the firm adding 398,800 shares to its holdings, reflecting a 2.62% change in the position size.

Related Keywords

United States , , Financial Health , Exelixis Inc Stock Performance , Growth Prospects Of Exelixis Inc , Exelixis Inc , Renaissance Technologies , Inc Stock Performance , Growth Prospects , Joel Greenblatt , First Eagle Investment , Richard Pzena , Jim Simons , Renaissance Technologie , Exelixis , Portfolio , Grades , Private Investment Firm , Biotechnology Industry , Investment Philosophy ,